EU recommends conditional approval for J&J's blood cancer drug

(Reuters) - European regulators recommended approving Johnson & Johnson's blood cancer drug with conditions on Friday, saying they would need to evaluate additional data from two ongoing studies on the antibody treatment.

http://ift.tt/1UIa9jx

from Reuters: Health News
via animenewspro